Jason Hoitt

Insider Reports History

Location
Bedford, MA
Signature
/s/ Jonathan Allan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Hoitt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. Chief Patient Officer Common Stock 10,276 $337,566 $32.85 18 Mar 2026 Direct
Stoke Therapeutics, Inc. Chief Patient Officer Employee Stock Option (Right to Buy) 72,000 17 Feb 2026 Direct
Stoke Therapeutics, Inc. Chief Patient Officer Restricted Stock Units 30,000 15 Mar 2026 Direct
Provention Bio, Inc. Chief Commercial Officer Option to Purchase Common Stock 0 27 Apr 2023 Direct

Insider Reports Filed by Jason Hoitt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STOK Stoke Therapeutics, Inc. 17 Mar 2026 5 -$119,311 4 Chief Patient Officer 19 Mar 2026, 17:58
STOK Stoke Therapeutics, Inc. 15 Mar 2026 2 $0 4 Chief Patient Officer 17 Mar 2026, 17:26
STOK Stoke Therapeutics, Inc. 17 Feb 2026 2 $0 4 Chief Patient Officer 19 Feb 2026, 16:21
STOK Stoke Therapeutics, Inc. 18 Jun 2025 0 $0 3 Chief Patient Officer 23 Jun 2025, 16:16
/report/000149315223013904-hoitt-jason-2023-04-27 Provention Bio, Inc. 27 Apr 2023 5 $0 4 Chief Commercial Officer 27 Apr 2023, 18:00
/report/000149315223005078-hoitt-jason-2023-02-10 Provention Bio, Inc. 10 Feb 2023 1 -$45,005 4 Chief Commercial Officer 14 Feb 2023, 18:16
/report/000149315223001208-hoitt-jason-2023-01-10 Provention Bio, Inc. 10 Jan 2023 1 $0 4 Chief Commercial Officer 11 Jan 2023, 20:10
/report/000149315222035096-hoitt-jason-2022-12-08 Provention Bio, Inc. 08 Dec 2022 2 $0 4 Chief Commercial Officer 09 Dec 2022, 19:31
/report/000149315222001752-hoitt-jason-2022-01-18 Provention Bio, Inc. 18 Jan 2022 1 $0 4 Chief Commercial Officer 20 Jan 2022, 16:20
/report/000149315221011579-hoitt-jason-2021-05-12 Provention Bio, Inc. 12 May 2021 1 $0 4 Chief Commercial Officer 14 May 2021, 19:39
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .